The collaboration will see DSM exclusively market and sell Panaceutics Nutrition personalized products in multiple markets across the Americas, Europe and Asia.
Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, and digital health provider Panaceutics are joining forces to bring affordable personalized nutrition products to the market, providing consumers with access to the specific nutrients they need for optimal health.
The collaboration will see DSM exclusively market and sell Panaceutics Nutrition personalized products in multiple markets across the Americas, Europe and Asia. As one of the only systems in the world that allows cost-effective and scalable manufacturing of individual formulations, Panaceutics uses patented technologies to combine digital data on daily habits, genomics and biomarkers. This then drives its on-demand robotic manufacturing platform to make an individual’s blended formula, delivered in a ready-to-consume, shelf-stable packaged product.
DSM is a minority investor in Panaceutics through its venture investment arm, DSM Venturing, and the companies will collaborate on several personalized health projects, including adapting Panaceutics’ exclusive technology to manufacture additional formats, such as personalized beverages and bars. Although the partnership with DSM focuses on personalized nutrition, the Panaceutics technology is also a significant tool in personalized medicine therapies, where it is already helping to prevent and manage medical conditions.